Dr. Gerald Tramontano conducts a variety of sponsored and investigator-initiated pharmacological, nutraceutical and neurodiagnostic research. As a Principal Investigator, Dr. Tramontano has completed approximately 70 clinical research studies. His clinical research experience in drug development ranges from bioavailabilty / bioequivalent studies, as well as, first in humans Phase I studies through Phase IV clinical trials. The majority of his clinical research has been investigating functional brain mapping, neuromodulation, behavioral, biological and pharmacological treatments for patients with a variety of cognitive and neuropsychiatric conditions, in particular – neurodegenerative diseases such as Alzheimer’s disease. He has authored several published neuroscience-related and pharmacology articles in medical and forensic journals. Dr. Tramontano specializes in the practice of clinical neuropsychology. He is also a Clinical Assistant Professor of Psychiatry at Rutgers Medical School and faculty member of the Cerebral Dysfunction Clinic at the medical school. He is an Assistant Professor in Psychology at St. John’s University teaching clinical neuropsychology in the Ph.D. Clinical Psychology Program. Read more about Dr. Tramontano.